Progyny (PGNY) | Stock Overview & Key Data

What is PGNY's 52-week high and low?

In the last 52 weeks, Progyny reached a high of $30.42 (on July 17, 2024) and a low of $13.39 (on November 15, 2024).

What is the market cap and P/E ratio for PGNY?

Curious about Progyny's size and valuation? Its market capitalization stands at 1.78B. When it comes to valuation, the P/E ratio (trailing twelve months) is 36.47, and the forward P/E (looking ahead) is 27.36.

Does PGNY pay dividends? If so, what's the yield?

As for dividends, Progyny isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Progyny's main competitors or similar companies to consider before investing?

When looking at Progyny, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
UnitedHealth UNH	277.19B	Healthcare	Healthcare Plans	-36.77%	-40.51%
Elevance Health ELV	84.14B	Healthcare	Healthcare Plans	-34.41%	-28.18%
Clover Health CLOV	1.44B	Healthcare	Healthcare Plans	101.57%	-3.40%
Cigna CI	84.68B	Healthcare	Healthcare Plans	0.20%	14.53%
CVS Health CVS	84.52B	Healthcare	Healthcare Plans	19.09%	-28.40%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Progyny Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Progyny's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.11%, the Debt to Equity ratio from the most recent quarter is 6.19, and its Gross Profit Margin stands at 23.39%.

What is the recent revenue and earnings growth for PGNY?

Looking at Progyny's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.50%, and quarterly earnings saw a YoY growth of -10.90%.

How much of PGNY stock is held by insiders and institutions?

Wondering who owns Progyny stock? Company insiders (like executives and directors) hold about 7.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 98.42%.

For more common questions about our data, please visit our About Data page.